Therapeutics - Shock Part 1 Flashcards

1
Q

shock is a syndrome of….

A

impaired tissue perfusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

if shock is left untreated/undertreated, ____ eventually wanes and ____ can occur

A

compensation eventually wanes and decompensation can occur

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

3 main types of shock and their general cause

A

hypovolemic (vol reduction)
cardiogenic (heart pump failure)
distributive (increased vascular compliance)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

septic shock falls under which of the 3 types

A

distributive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

true or false

determining the type of shock is not important to manage it

A

FALSE - it is important

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what is the hallmark of septic shock?
explain what it is

A

SIRS (systemic inflammatory response syndrome)
-profound vasodilation
-increased capillary permeability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

increased capillary permeability seen in septic shock causes what

A

edema - fluid leaves the intravascular compartment and goes into the interstitial compartmner

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

septic shock most commonly occurs from what

A

infection (typically bacterial)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

explain when a patient meets SIRS criteria

A

have to meet 2 or more of these abnormalities:

-temperature
-high heart rate
-high respiration rate
-WBC high or low

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

explain the criteria for someone to have sepsis

A

have to meet 2 or more of the SIRS criteria (temp, white count, respiration rate, heart rate), AND a suspected source of infection has to exist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is the main determinant of tissue perfusion and how is it calculated

A

MAP (mean arterial pressure) – average pressure that drives the blood throughout the organs

ABP + DBP + DBP
all divided by 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MAP is a function of….

A

cardiac output * systemic vascular resistance (SVR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

cardiac output is a function of….

A

heart rate * stroke volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

name some clinical presentation features of a shock patient

A

tachycardia (over 90)
tachypnea (over 20 breaths/min)
mental confusion
oliguria (less than 20mL/hour)
mental confusion
skin vasoconstriciton (cold and pale)
acidosis

systolic BP less than 90 or a DROP over 60 from baseline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

why do shock patients tend to have tachycardia (over 90 bpm) and tachypnea (over 20 breaths/min)

A

because the body is trying to compensate for the lack of blood flow and oxygen to the tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

3 signs of organ damage from shock

A

oliguria
mental confusion
metabolic acidosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

when would we do invasive vs noninvasive hemodynamic monitoring in shock patients

A

invasive is only necessary in critically ill patients

noninvasive typically used - provides limited info but valuble info

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

true or false

an echocardiogram is considered a NONINVASE hemodynamic monitoring strategy

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

3 methods of invasive monitoring to watch hemodynamic control

A

arterial line
central venouos catheter
pulmonary artery catheter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

true or false

arterial lines used to monitor hemodynamics in shock patients can be used to administer meds

A

FALSE - only central venous catheter can

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

which invasive hemodynamic monitoring method allows the measurement of CO (cardiac output) and PCWP (pulmonary capillary wedge pressure)

A

pulmonary artery catheter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

which value is the best indicator for preload? represents total body volume

A

PCWP (pulmonary capillary wedge pressure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

name what is FIRST AFFECTED In each shock:

hypovolemic
cardiogenic
distributive

A

hypovolemic - decreased cardiac output and preload 9PCWP) is first

cardiogenic - decreased cardiac output is first

distributive - decreased SVR (systemic vascular resistance) is first

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

true or false

all of the 3 types of shock cause an increased HR

A

true

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

when EDV (end diastolic volume )is affected, what kind of shock is this?

what about when ESY (end systolic volume) is affected

A

EDV affected - hypovolemic shock

ESV affected - cardiogenic shock

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

as mentioned, when a patient loses volume, compensation will occur and the SVR and heart rate will increase.

what happens when these compensatory mechanisms are overcome

A

blood pressure will decrease, along with perfusion to orfans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

true or false

in cardiogenic shock, cardiac output decreases, but this is NOT due to a loss in volume

28
Q

general treatment goals for shock patients

A

regain hemodynamic control
reverse the cause!
stop organ dysfunction

29
Q

goal for treatment in hypovolemic shock

A

correct inadequate tissue perfusion and oxygenation by INCREASING THE INTRAVASCULAR VOLUME

30
Q

as mentioned, in hypovolemic shock, we hope to fix inadequate tissue perfusion by increasing the intravacular volume

what is an important consideration about this

A

DO NOT FLUID OVERLOAD! (Can cause something like pulmonary edema)

31
Q

3 potential options for fluid replacement in hypovolemic shock patient

A

crystalloids
colloids
blood

32
Q

what is the primary intervention in hypovolemic shock

A

infusion of IV fluids

33
Q

which fluid is considered 1st line in hypovolemic shock

A

crystalloids ( ie - dextrose, NS, LR, hypertonic saline

34
Q

differentiate between the general volumes of crystalloids vs colloids in hypovolemic shock patients

A

crystalloids - need a larger volume. this is bc colloids stay in the intravascular space more
crystalloids shift more to the extravascular space

35
Q

general approach to the volume of crystalloids to be given in shock patients

A

1-2L (only 25% stays in intravascular space) of isotonic fluid as fast as possible, and then additional fluid as necessary

36
Q

4 examples of crystalloids

A

NS, hypertonic saline, lactated ringer’s, dextrose

37
Q

*important crystalloid to AVOID when replacing fluid and why

A

D5W

it is an ineffective osmole. water will not stay in the vein like normal saline and other things

38
Q

name some colloids

which is preferred

A

albumin 5% (isotonic) or 25% (hypertonic), dextrans, hydroxyethyl starch(es)

all are considered equally effective

39
Q

true or false

compared to crystalloids, colloids need to be given for a longer duration and a LOWER volume

40
Q

potential concerns with albumin

A

-hypersensitivity reactions

-potential increased mortality in burn/trauma patients – but this is still inconclusive

41
Q

true or false

effective osmoles stay in the extracellular space

A

TRUE - therefore, water also stays in the extracellular space (blood vessels)

ineffective osmoles cross freely into the INTRACELLULAR space

42
Q

true or false

in a hypovolemic shock patient, the decision to give blood transfusions is solely based on the hemoglobin and hematocrit

A

FALSE - not solely based on this

based on clinical evidence - if pt is hypovolemic and has severe blood loss for instance

43
Q

some AE of giving blood transfusions for hypovolemic shock

A

electrolyte abnormalities
hemolysis
infectious disease
immunosuppression, etc

44
Q

general goals when giving a blood transfusion in a hypovolemic shock patient

A

1 unit of packed red blood cells (~200mL) should increase the hemoglobin by 1g/dL and the hematocrit by 3%

45
Q

goal in treating CARDIOGENIC shock

A

correct inadequate perfusion and oxygenation by IMPROVING CARDIAC FUNCTION

46
Q

3 intervention choices for cardiogenic shock

can they all be used together?

A

fluid challenge
inotropic support
vasodilators

yes can use combo

47
Q

explain the fluid challenge and its effect for cardiogenic shock

A

purpose of the fluid challenge is to see if the patient is hypovolemic. if they are – we have to correct that first or there will be AE

will increase the PCWP

the fluid challenge is done by giving a small amount of fluid like 100mL of normal saline, and then the cardiac output is reevaluated.

if the cardiac output didnt improve from that volume added. it is UNLIKELY to benefit from more fluid and hypovolemia can be ruled out

48
Q

true or false

if a patient’s cardiac output increased with the fluid challenge, but cardiac output is still at goal, we can switch to an inotrope or vasodilator

A

false - can ADD inotropes or vasodilators

as long as the patient’s cardiac output did in fact respond to the fluid challenge

49
Q

explain what inotropic support does in patients with cardiogenic shock

A

increases MAP by increasing cardiac performance

50
Q

disadvantage of inotropic support for cardiogenic shock

A

while it does increase cardiac performance and thus MAP, it also increase heart oxygen consumption — leading to potential increased mortality in heart failure patients

51
Q

true or false

inotropes increase cardiac output by increasing heart rate, contractility, and ventricular wall tension

52
Q

explain the genera; approach and dosing to inotropic agents for cardiogenic shock

it can only be given via what route?

A

give AFTER the volume has been repleted.

titrate by 1-2mcg/kg/min every 10 mins to get to the LOWEST EFFECTIVE DOSE that achieves the goal but AVOID tachycardia

only given through central line

53
Q

true or false

if a cardiogenic shock patient’s blood pressure is very low, we can give a vasodilator but do NOT give inotropic agents

A

FALSE

DO NOT GIVE A VASODILATOR!
inotropic agents are better option to not further decrease the BP

54
Q

goal MAP range for cardiogenic shock patients

55
Q

goal HR in cardiogenic shock patient

A

less than 110 bpm

56
Q

true or false

inotropic agents can be given through central line ONLY

57
Q

name 3 potential inotropic agents for cardiogenic shock

A

dopamine
dobutamine
epinephrine

58
Q

dobutamine is ______ tachycardic than dopamine

59
Q

explain what happens as the dose of dopamine increases

A

2-5mcg/kg/min — primarily only B1 stimulation that b blockers can inhibit

5-10mcg/kg/min - B1 AND alpha stimulation which usually increases the MAP and PCWP

15mcg-20mcg/kg/min and higher - primarily a1 stimulation that can cause cardiac irritability

60
Q

true or false

dobutamine is less tachycardic than dopamine. It generally decreases the SVR and PCWP as the dose increases

61
Q

true or false

the effects of dobutamine are impaired by beta blockers

62
Q

dose of dobutamine and its effect

A

2.5-15mcg/kg/min

b1 and b2 stimulation that exceeds a1 constriction

net vasodilation! but this is impaired by b blockers

63
Q

true or false

as the dose of epinephrine increases, the SVR tends to decrease

A

false - as dose of epi increases SVR also tends to increase

64
Q

varying doses of epi and its effects

A

0.01-0.1 mcg/kg/min - B1 stimulation

over 0.1mcg/kg/min - alpha 1 stimulation